Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionUtah Retirement Systems
Latest Disclosed Ownership15,720 shares
Latest Disclosed Value $ 2,070,953
Utah Retirement Systems reports 1.63% decrease in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 15, 2026 - Utah Retirement Systems filed a 13F-HR form disclosing ownership of 15,720 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $2,070,953 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 15,981 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -1.63% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,720 -261 -1.63 2,071 -8.65 0.0212
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,981 0 0.00 2,267 1.03 0.0216
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,981 -321 -1.97 2,243 9.52 0.0218
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,302 -281 -1.69 2,049 11.67 0.0214
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,583 0 0.00 1,834 -18.96 0.0212
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,583 100 0.61 2,264 19.17 0.0249
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,483 0 0.00 1,899 -16.31 0.0214
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,483 -200 -1.20 2,269 -1.35 0.0269
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,683 0 0.00 2,301 4.64 0.0269
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,683 0 0.00 2,198 17.16 0.0280
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,683 100 0.60 1,877 20.03 0.0268
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,583 -200 -1.19 1,564 -7.95 0.0217
2023-05-16 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,783 0 0.00 1,699 -15.27 0.0246
2023-02-15 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,783 -200 -1.18 2,005 11.09 0.0318
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,983 300 1.80 1,804 10.88 0.0301
2022-08-16 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,683 0 0.00 1,627 4.03 0.0260
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,683 -300 -1.77 1,564 8.16 0.0208
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,983 0 0.00 1,446 -11.23 0.0179
2021-11-16 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,983 -800 -4.50 1,629 -5.89 0.0220
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,783 100 0.57 1,731 0.64 0.0223
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,683 -800 -4.33 1,720 -2.93 0.0240
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,483 800 4.52 1,772 4.17 0.0252
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,683 200 1.14 1,701 -20.25 0.0282
2020-08-13 2020-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 17,483 300 1.75 2,133 43.44 0.0391
2020-08-13 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,483 300 2,133 39,149.1798
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,183 0 0.00 1,487 -19.49 0.0322
2020-02-12 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,183 0 0.00 1,847 19.32 0.0325
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,183 100 0.59 1,548 7.35 0.0295
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,083 102 0.60 1,442 -3.61 0.0276
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,981 381 2.30 1,496 26.24 0.0296
2019-02-08 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,600 100 0.61 1,185 -41.60 0.0268
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,500 0 0.00 2,029 25.25 0.0393
2018-08-10 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,500 0 0.00 1,620 18.33 0.0335
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,500 200 1.23 1,369 8.22 0.0291
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,300 300 1.88 1,265 29.08 0.0266
2017-11-13 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,000 0 0.00 980 33.15 0.0220
2017-08-08 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,000 300 1.91 736 8.24 0.0172
2017-05-11 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,700 0 0.00 680 11.84 0.0163
2017-02-10 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,700 100 0.64 608 -23.04 0.0153
2016-11-07 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,600 0 0.00 790 11.42 0.0204
2016-08-03 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,600 15,600 709 0.0189
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.